Position in NVS
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,044,381
+$26,456 QoQ
Shares Held
6,664
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#605
of 1,603 holders
Holding Since
Sep 2020
8 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIRST HORIZON CORP holds $143,998,536 across 15 Drug Manufacturers - General names. NVS ranks #9 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
141,165 | $35,851,674 | |
| 2 | AMGN |
Amgen Inc
|
63,631 | $23,042,057 | |
| 3 | MRK |
Merck & Co., Inc.
|
156,209 | $20,072,856 | |
| 4 | ABBV |
AbbVie Inc.
|
73,329 | $18,452,509 | |
| 5 | LLY |
ELI LILLY & Co
|
13,439 | $16,119,140 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
213,224 | $12,285,966 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
65,698 | $8,300,285 | |
| 8 | PFE |
Pfizer Inc
|
342,754 | $8,253,516 |
All Filings in NVS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,044,381 | 6,664 | Shares | Defined | 2026-07-20 | |
| 2026-03-31 | $1,017,925 | 6,664 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $918,765 | 6,664 | Shares | Defined | 2026-01-27 | |
| 2025-09-30 | $854,590 | 6,664 | Shares | Defined | 2025-10-27 | |
| 2021-06-30 | $1,227,634 | 13,455 | Shares | Defined | 2021-08-09 | |
| 2021-03-31 | $1,150,133 | 13,455 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $1,281,131 | 13,567 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $1,179,612 | 13,565 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||